Continuing Medical Education For HCPs
Staying updated with the latest advancements in rare disease care is crucial for healthcare professionals. Our Continuing Medical Education (CME) resources offer in-depth insights into the evolving landscape of rare disease care. Explore a range of educational materials designed to empower medical professionals with the knowledge needed to offer the best possible care to rare disease patients. Stay informed about the latest treatment approaches, specialized care strategies, and innovative rare disease solutions.
Sponsored By
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Older woman with ovarian cancer have a worse prognosis compared to younger patients.
However, the reason is not known.
Currently, the standard of care is to evaluate younger and older pat ...
Condition: Ovarian Cancer
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa
This research study is a Phase II clinical trial.
Phase II clinical trials test the effectiveness of an investigational drug, which is cisplatin in this trial, to learn how well it works in tr ...
Condition: Breast Cancer
Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer
This study is comparing the safety and effectiveness of abiraterone acetate alone, followed by the addition of prednisone (when the participant's disease worsens or the physician feels it would l ...
Condition: Castration-resistant Prostate Cancer
Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study
Background: Blinatumomab is a bispecific T-cell engager approved for the treatment of relapse/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL). Most studies evaluating blinatumomab were cond
Severe outcomes and risk factors of non-neutropenic fever episodes in hospitalized children with cancer in Kenya
Introduction: Compared to febrile neutropenia (FN), non-neutropenic fever (NNF) episodes in children with cancer have not been associated with severe outcomes. Risk factors for severe outcomes in FN a
Mesenchymal stromal cells for steroid-refractory biopsy-proven grade III-IV acute Graft-versus-Host Disease with predominant gastrointestinal involvement
Introduction: Steroid-refractory acute Graft-versus-Host Disease (SR-aGVHD) is a potentially fatal complication occurring in approximately 60-70% of severe grade III-IV GVHD cases, with a higher incid
Utilizing the 4Kscore at Kasraeian Urology
Ali Kasraeian, MD, of Kasraeian Urology in Jacksonville, FL shares his thoughts on how the 4Kscore opens up a reasonable ...
Everything You Need to Know About Becoming a Urologist 🩺 In USA 🇺🇸
shorts Ready for a wild ride? I'm spilling the beans on everything you need to know about becoming a urologist. From the ...
Consult senior Urologist 24/7
Fix your appointment to: Unittas Multi-speciality Hospital 044-40124012 / 8072046626 - #urology #urologia #urologist #health ...